Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.02
MWIV's Cash to Debt is ranked lower than
64% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.78 vs. MWIV: 0.02 )
MWIV' s 10-Year Cash to Debt Range
Min: 0   Max: No Debt
Current: 0.02

Equity to Asset 0.47
MWIV's Equity to Asset is ranked higher than
67% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.37 vs. MWIV: 0.47 )
MWIV' s 10-Year Equity to Asset Range
Min: 0.05   Max: 0.64
Current: 0.47

0.05
0.64
Interest Coverage 140.51
MWIV's Interest Coverage is ranked higher than
81% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 7.81 vs. MWIV: 140.51 )
MWIV' s 10-Year Interest Coverage Range
Min: 2.06   Max: 167.2
Current: 140.51

2.06
167.2
F-Score: 5
Z-Score: 5.96
M-Score: -2.25
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 4.27
MWIV's Operating margin (%) is ranked higher than
67% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.78 vs. MWIV: 4.27 )
MWIV' s 10-Year Operating margin (%) Range
Min: 2.57   Max: 4.41
Current: 4.27

2.57
4.41
Net-margin (%) 2.68
MWIV's Net-margin (%) is ranked higher than
67% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.80 vs. MWIV: 2.68 )
MWIV' s 10-Year Net-margin (%) Range
Min: 0.64   Max: 2.72
Current: 2.68

0.64
2.72
ROE (%) 14.74
MWIV's ROE (%) is ranked higher than
83% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.25 vs. MWIV: 14.74 )
MWIV' s 10-Year ROE (%) Range
Min: 5.26   Max: 1068.27
Current: 14.74

5.26
1068.27
ROA (%) 7.83
MWIV's ROA (%) is ranked higher than
87% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.39 vs. MWIV: 7.83 )
MWIV' s 10-Year ROA (%) Range
Min: 1.72   Max: 8.44
Current: 7.83

1.72
8.44
ROC (Joel Greenblatt) (%) 29.93
MWIV's ROC (Joel Greenblatt) (%) is ranked higher than
67% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 34.71 vs. MWIV: 29.93 )
MWIV' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 19.82   Max: 30.67
Current: 29.93

19.82
30.67
Revenue Growth (%) 23.00
MWIV's Revenue Growth (%) is ranked higher than
87% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.60 vs. MWIV: 23.00 )
MWIV' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 29
Current: 23

0
29
EBITDA Growth (%) 22.00
MWIV's EBITDA Growth (%) is ranked higher than
72% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.10 vs. MWIV: 22.00 )
MWIV' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 27.9
Current: 22

0
27.9
EPS Growth (%) 22.40
MWIV's EPS Growth (%) is ranked higher than
85% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.60 vs. MWIV: 22.40 )
MWIV' s 10-Year EPS Growth (%) Range
Min: 0   Max: 64.7
Current: 22.4

0
64.7
» MWIV's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

MWIV Guru Trades in Q2 2013

Paul Tudor Jones 3,700 sh (New)
Jim Simons 4,422 sh (New)
Chuck Royce 10,000 sh (unchged)
Mario Gabelli 56,200 sh (-3.44%)
Steven Cohen 883 sh (-96.45%)
» More
Q3 2013

MWIV Guru Trades in Q3 2013

Joel Greenblatt 11,835 sh (New)
Jim Simons 7,600 sh (+71.87%)
Chuck Royce 10,000 sh (unchged)
Steven Cohen Sold Out
Paul Tudor Jones Sold Out
Mario Gabelli 52,800 sh (-6.05%)
» More
Q4 2013

MWIV Guru Trades in Q4 2013

Jim Simons 25,200 sh (+231.58%)
Chuck Royce 10,000 sh (unchged)
Mario Gabelli 51,100 sh (-3.22%)
Joel Greenblatt 7,647 sh (-35.39%)
» More
Q1 2014

MWIV Guru Trades in Q1 2014

Paul Tudor Jones 4,600 sh (New)
Steven Cohen 1,769 sh (New)
Chuck Royce 10,000 sh (unchged)
Joel Greenblatt Sold Out
Mario Gabelli 50,400 sh (-1.37%)
Jim Simons 9,100 sh (-63.89%)
» More
» Details

Insider Trades

Latest Guru Trades with MWIV

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-03-31 Sold Out 0.03%$150.5 - $186.26 $ 142.98-15%0
Joel Greenblatt 2013-12-31 Reduce -35.39%0.02%$151.43 - $182.17 $ 142.98-14%7647
Joel Greenblatt 2013-09-30 New Buy0.06%$119.35 - $155.01 $ 142.981%11835
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 27.60
MWIV's P/E(ttm) is ranked higher than
68% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 29.80 vs. MWIV: 27.60 )
MWIV' s 10-Year P/E(ttm) Range
Min: 12.17   Max: 52.12
Current: 27.6

12.17
52.12
P/B 4.00
MWIV's P/B is ranked higher than
52% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.40 vs. MWIV: 4.00 )
MWIV' s 10-Year P/B Range
Min: 1.35   Max: 5.47
Current: 4

1.35
5.47
P/S 0.70
MWIV's P/S is ranked higher than
73% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.69 vs. MWIV: 0.70 )
MWIV' s 10-Year P/S Range
Min: 0.3   Max: 0.99
Current: 0.7

0.3
0.99
PFCF 57.90
MWIV's PFCF is ranked higher than
68% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 39.22 vs. MWIV: 57.90 )
MWIV' s 10-Year PFCF Range
Min: 15.63   Max: 1329.67
Current: 57.9

15.63
1329.67
EV-to-EBIT 18.28
MWIV's EV-to-EBIT is ranked higher than
68% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.20 vs. MWIV: 18.28 )
MWIV' s 10-Year EV-to-EBIT Range
Min: 7.5   Max: 24
Current: 18.28

7.5
24
PEG 1.10
MWIV's PEG is ranked higher than
86% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.13 vs. MWIV: 1.10 )
MWIV' s 10-Year PEG Range
Min: 0.72   Max: 1.47
Current: 1.1

0.72
1.47
Shiller P/E 39.00
MWIV's Shiller P/E is ranked higher than
75% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 81.61 vs. MWIV: 39.00 )
MWIV' s 10-Year Shiller P/E Range
Min: 27.86   Max: 55.37
Current: 39

27.86
55.37
Current Ratio 1.60
MWIV's Current Ratio is ranked higher than
70% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.53 vs. MWIV: 1.60 )
MWIV' s 10-Year Current Ratio Range
Min: 1.07   Max: 2.29
Current: 1.6

1.07
2.29
Quick Ratio 0.78
MWIV's Quick Ratio is ranked lower than
52% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.01 vs. MWIV: 0.78 )
MWIV' s 10-Year Quick Ratio Range
Min: 0.59   Max: 1.26
Current: 0.78

0.59
1.26

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 5.20
MWIV's Price/Tangible Book is ranked higher than
64% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 7.94 vs. MWIV: 5.20 )
MWIV' s 10-Year Price/Tangible Book Range
Min: 2.35   Max: 6.61
Current: 5.2

2.35
6.61
Price/DCF (Projected) 3.00
MWIV's Price/DCF (Projected) is ranked higher than
71% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.73 vs. MWIV: 3.00 )
MWIV' s 10-Year Price/DCF (Projected) Range
Min: 2.13   Max: 4.56
Current: 3

2.13
4.56
Price/Median PS Value 1.10
MWIV's Price/Median PS Value is ranked higher than
73% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.35 vs. MWIV: 1.10 )
MWIV' s 10-Year Price/Median PS Value Range
Min: 0.57   Max: 1.46
Current: 1.1

0.57
1.46
Price/Peter Lynch Fair Value 1.10
MWIV's Price/Peter Lynch Fair Value is ranked higher than
87% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 9999.00 vs. MWIV: 1.10 )
MWIV' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.74   Max: 1.34
Current: 1.1

0.74
1.34
Price/Graham Number 2.50
MWIV's Price/Graham Number is ranked higher than
70% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.25 vs. MWIV: 2.50 )
MWIV' s 10-Year Price/Graham Number Range
Min: 1.27   Max: 3.5
Current: 2.5

1.27
3.5
Earnings Yield (Greenblatt) 5.60
MWIV's Earnings Yield (Greenblatt) is ranked higher than
64% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.10 vs. MWIV: 5.60 )
MWIV' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4.2   Max: 13.4
Current: 5.6

4.2
13.4
Forward Rate of Return (Yacktman) 24.91
MWIV's Forward Rate of Return (Yacktman) is ranked higher than
79% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.64 vs. MWIV: 24.91 )
MWIV' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 15.7   Max: 28.2
Current: 24.91

15.7
28.2

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, MCK, CAH, SHTDF, HSIC » details
Traded in other countries:M4D.Germany
MWI Veterinary Supply, Inc. commenced operations as part of a veterinary practice in 1976 and was incorporated as MWI Drug Supply, Inc., an Idaho corporation, in 1980. The Company is a distributor of animal health products. Its products include pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, supplies, specialty products, veterinary pet food, capital equipment & nutritional products. It markets these products to veterinarians in both the companion animal and production animal markets. It also offers its customers services, including its e-commerce platform, technology management systems, pharmacy fulfillment, inventory management system, equipment procurement consultation, special order fulfillment, educational seminars and pet cremation. As of September 30, 2012, it distributed its products from fourteen strategically located distribution centers throughout the United States and one in the United Kingdom. The Company competes with numerous vendors and distributors based on customer relationships, service and delivery, product selection, price and e-commerce capabilities. Certain of it businesses involve the distribution of pharmaceuticals, and in this regard it is subject to various local, state, federal and foreign governmental laws and regulations applicable to the distribution of pharmaceuticals.
» More Articles for MWIV

Headlines

Articles On GuruFocus.com
President and CEO of MWI Vet Supply James F. Cleary Jr. Sold 76,394 shares Jun 19 2012 
MWI Veterinary Supply Inc. (MWIV) Senior VP, Secretary and CFO Mary Patricia B Thompson sells 1,000 Mar 03 2011 
MWI Veterinary Supply Inc. (MWIV) Senior VP, Secretary and CFO Mary Patricia B Thompson sells 3,000 Feb 16 2011 
MWI Veterinary Supply Inc. Reports Operating Results (10-Q) Feb 03 2011 
MWI Veterinary Supply Inc. (MWIV) President and CEO James F Jr Cleary sells 25,900 Shares Nov 18 2010 
MWI Veterinary Supply Inc. (MWIV) Senior VP, Secretary and CFO Mary Patricia B Thompson sells 12,000 Sep 22 2010 
MWI Veterinary Supply Inc. (MWIV) Senior VP, Secretary and CFO Mary Patricia B Thompson sells 1,500 Sep 02 2010 
MWI Veterinary Supply Inc. (MWIV) Senior VP, Secretary and CFO Mary Patricia B Thompson sells 1,500 Aug 03 2010 
MWI Veterinary Supply Inc. Reports Operating Results (10-Q) Jul 29 2010 
MWI Veterinary Supply Inc. (MWIV) Senior VP, Secretary and CFO Mary Patricia B Thompson sells 1,500 Jul 06 2010 

More From Other Websites
MWI VETERINARY SUPPLY, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 31 2014
MWI Veterinary Supply Announces 2014 Third Quarter Results and Updates Fiscal 2014 Guidance Jul 31 2014
7:13 am MWI Veterinary Supply reports EPS in-line, beats on revs; guides FY14 EPS in-line, revs... Jul 31 2014
Q3 2014 MWI VETERINARY SUPPLY INC Earnings Release - Before Market Open Jul 31 2014
MWI Veterinary Supply Announces 2014 Third Quarter Results and Updates Fiscal 2014 Guidance Jul 31 2014
INVESTOR ALERT - MWI Veterinary Supply, Inc.: The Law Offices of Vincent Wong Launch an... Jul 25 2014
MWI VETERINARY SUPPLY, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement,... Jul 25 2014
MWI Veterinary Supply, Inc. Announces Its Third Quarter Fiscal Year 2014 Earnings Release Date and... Jul 24 2014
MWI Veterinary Supply, Inc. Announces Its Third Quarter Fiscal Year 2014 Earnings Release Date and... Jul 24 2014
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into MWI... Jul 14 2014
MWI Vet Upgraded to Strong Buy on Solid Fundamentals Jul 09 2014
MWI Veterinary Supply (MWIV) Looks Good: Stock Adds 5.1% in Session May 15 2014
MWI VETERINARY SUPPLY, INC. Financials May 14 2014
Will This Coverage Initiation Help MWI Veterinary Supply (MWIV) Stock Today? (Update) May 14 2014
MWI Veterinary Supply initiated with a Buy at UBS May 14 2014
MWI Veterinary Misses on Q2 Earnings, Shares Sink May 08 2014
Is MWI Veterinary Supply (MWIV) Ready to Breakout? May 07 2014
MWI Veterinary Supply (MWIV) in Focus: Stock Tanks 11.7% May 07 2014
MWI Veterinary Supply's (MWIV) CEO Jim Cleary on Q2 2014 Results - Earnings Call Transcript May 06 2014
MWI VETERINARY SUPPLY, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 06 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide